Dr. Jonathan Li is an Assistant Professor of Medicine at Harvard Medical School and a faculty member in the Division of Infectious Diseases at the Brigham and Women’s Hospital.  His research is focused on HIV drug resistance, reservoirs, and HIV remission. He is active in the AIDS Clinical Trials Group (ACTG) as a member of the ACTG HIV Reservoirs and Viral Eradication Transformative Science Group, a representative in the ACTG Executive Committee, and as the Chair of several ACTG clinical trials. He is the Deputy Editor of the IDSA journal Open Forum Infectious Diseases and on the Editorial Advisory Board of the Journal of Infectious Diseases. In addition, he sees patients in both the outpatient Infectious Diseases clinic and on the inpatient consult service at the Brigham and Women’s Hospital. Current research projects include the

  • Predictors of HIV rebound after treatment interruption and post-treatment virologic control
  • Impact of HIV minority variants using next-generation sequencing
  • HIV integration into the human genome
  • Mechanisms and clinical impact of persistent low-level HIV viremia despite antiretroviral therapy
  • Clinical and translational research in coronaviruses and COVID-19 disease

The Li Laboratory is located in Cambridge MA, and is associated with Brigham and Women’s Hospital and Harvard Medical School.

Contact Information

Jonathan Li, MD, MMSc

Partners Research Building

65 Landsdowne Street, Rm 421

Cambridge, MA 02139

Phone: (617)-768-8476

Fax: (617)-768-8738

Email: jli@bwh.harvard.edu